Yan Z, Chen FQ. Effect of chronic hepatitis B on liver function, serum lipids, blood glucose and insulin in patients with NAFLD.
Shijie Huaren Xiaohua Zazhi 2016;
24:3523-3528. [DOI:
10.11569/wcjd.v24.i23.3523]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To detect the variations of liver function, serum lipids, blood glucose and insulin levels in patients with non-alcoholic fatty liver disease (NAFLD) accompanied by chronic hepatitis B (CHB).
METHODS: A total of 88 patients with fatty liver treated at our hospital from January 2014 to December 2015 were recruited in this study, which included 39 patients with NAFLD alone and 37 patients with NAFLD combined with CHB. Thirty-eight people who underwent a medical examination at our hospital during the same period were recruited as a control group. The levels of liver function indicators, serum lipids, blood glucose and insulin in the three groups were detected and compared.
RESULTS: The levels of total bilirubin (TBIL), direct bilirubin (DBIL), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma glutamyl transpeptidase (GGT) in patients with NAFLD alone and those with NAFLD combined with CHB were significantly higher than those in the control group, and the levels of TBIL, DBIL, ALT, AST and GGT in patients with NAFLD combined with CHB were significantly higher than those in patients with NAFLD alone (P < 0.05). The levels of low density lipoprotein (LDL), cholesterol (TC) and triglyceride (TG) in patients with NAFLD alone and those with NAFLD combined with CHB were significantly higher than those in the control group, and the levels of LDL, TC and TG in patients with NAFLD combined with CHB were higher than those in patients with NAFLD alone (P < 0.05). The levels of fasting insulin in patients with NAFLD alone and those with NAFLD combined with CHB were significantly higher than those in the control group (P < 0.05), although there was no significant difference in the levels of fasting plasma glucose in the three groups (P > 0.05). The levels of insulin sensitivity index (ISI) were significantly lower in patients with NAFLD alone and those with NAFLD combined with CHB than in the control group, and in patients with NAFLD combined with CHB than in patients with NAFLD alone (P < 0.05).
CONCLUSION: If NAFLD patients are infected with hepatitis B virus, the insulin sensitivity of the patients will decrease with metabolic disorder and liver damage will be aggravated．
Collapse